Aptose Biosciences Stock Quote APTO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.71

Bid

1.51

Ask

1.73

Volume

0.00 Day's Range 0.00

1.35 52 Week Range 25.689

Market Cap

4.365M

Previous Close

1.71

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

12,129

Shares Outstanding

2,552,429

Dividend Yield

PE Ratio

-0.45

Earnings Per Share (EPS)

-9.96

Revenue

Net Profit

-25.43M

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Lux... Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptose.com

Headquarters

Mississauga, Ontario, Can

Founded

Aptose Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APTO. The last closing price for Aptose Biosciences was $1.71. Over the last year, Aptose Biosciences shares have traded in a share price range of $ 1.35 to $ 25.689.

Aptose Biosciences currently has 2,552,429 shares outstanding. The market capitalization of Aptose Biosciences is $4.36 million. Aptose Biosciences has a price to earnings ratio (PE ratio) of -0.45.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial

Aptose is developing TUS+VEN+AZA as a one-of-a-kind safe and mutation agnostic frontline triple drug therapy...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	1.71	1.71	1.71	0	0	CS
4	0	0	1.71	1.71	1.71	0	0	CS
12	-1.61	-48.4939759036	3.32	3.43	1.35	12129	1.84190163	CS
26	-6.39	-78.8888888889	8.1	11.685	1.35	5591714	7.12237089	CS
52	-23.49	-93.2142857143	25.2	25.689	1.35	3227283	7.19377718	CS
156	-380.79	-99.5529411765	382.5	414	1.35	1180806	28.43967466	CS
260	-3022.29	-99.943452381	3024	3285	1.35	1261834	891.9963741	CS

APTO - Frequently Asked Questions (FAQ)

What is the current Aptose Biosciences share price?

The current share price of Aptose Biosciences is $ 1.71

How many Aptose Biosciences shares are in issue?

Aptose Biosciences has 2,552,429 shares in issue

What is the market cap of Aptose Biosciences?

The market capitalisation of Aptose Biosciences is USD 4.36M

What is the 1 year trading range for Aptose Biosciences share price?

Aptose Biosciences has traded in the range of $ 1.35 to $ 25.689 during the past year

What is the PE ratio of Aptose Biosciences?

The price to earnings ratio of Aptose Biosciences is -0.45

What is the reporting currency for Aptose Biosciences?

Aptose Biosciences reports financial results in USD

What is the latest annual profit for Aptose Biosciences?

The latest annual profit of Aptose Biosciences is USD -25.43M

What is the registered address of Aptose Biosciences?

The registered address for Aptose Biosciences is 5955 AIRPORT ROAD, MISSISSAUGA, ONTARIO, L4V 1R9

What is the Aptose Biosciences website address?

The website address for Aptose Biosciences is www.aptose.com

Which industry sector does Aptose Biosciences operate in?

Aptose Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
INVZWInnoviz Technologies Ltd	$ 0.1212 (34.22%)	300
NUWENewellis Inc	$ 0.3551 (31.11%)	10.59M
CISSC3is Inc	$ 3.98 (11.17%)	103.23k
OSRHOSR Holdings Inc	$ 1.6799 (10.52%)	4.1k
MOVEMovano Inc	$ 0.80 (9.97%)	323
NXXTNextNRG Inc	$ 2.30 (-23.59%)	281
ICGIntchains Group Ltd	$ 1.26 (-16.00%)	8.14k
MRINMarin Software Incorporated	$ 1.13 (-13.74%)	222.66k
LGCLLucas GC Ltd	$ 0.90 (-13.52%)	200k
GAMEGameSquare Holdings Inc	$ 0.6801 (-10.74%)	2.32k
NUWENewellis Inc	$ 0.3551 (31.11%)	10.59M
AURAurora Innovations Inc	$ 5.25 (0.96%)	4.6M
SOFISoFi Technologies Inc	$ 15.22 (0.20%)	3.95M
PEPPepsiCo Inc	$ 129.39 (0.25%)	2.87M
NXTTNext Technology Holding Inc	$ 3.19 (-7.54%)	2.47M